Mixed Reality in MitraClip Implantation: Preliminary Case Series
ConditionMitral Regurgitation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNemocnice AGEL Trinec-Podlesi a.s.
About this trial
The study aims to evaluate the impact of mixed reality (MR) technology, particularly using Hololens 2.0 and specialized software for three-dimensional DICOM image visualization, on MitraClip implantation procedures. This preliminary case series includes a comparative analysis of four MitraClip implantations, assessing procedural efficiency, radiation exposure, and operator stress through both physiological and subjective measures.
Eligibility criteria
Qualifiers
Adults aged over 18 years
Patients diagnosed with mitral valve regurgitation requiring MitraClip implantation
Ability to provide informed consent and comply with study procedures
Disqualifiers
Patients with contraindications for MR technology (e.g., MRI incompatibility)
Individuals unable to comply with study procedures due to physical or cognitive impairments
Pregnant or breastfeeding women
Trial design
Treatments tested in this trial
- MitraClip implantation
Treatment groups
14 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov